BackBiocept Overview

Biocept Inventory

Biocept's inventory is $550K.

Get informed when a big investor buys or sells

+ Follow
Inventory
$551000.00
↓ 75.50% YoYΔ $-1.70M vs prior year quarter

Peer average / median

Loading

Biocept Inventory History

Loading

Biocept vs. peers: Inventory Comparison

Loading

Biocept Inventory Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Biocept (BIOC) FAQ

Biocept (BIOC) currently reports a inventory of $550K as of June 2023. That compares with $2.2M in the prior-year period — down 75.5% year over year. Use the charts on this page to explore Biocept's inventory history and peer comparisons.

Biocept's inventory decreased from $2.2M to $550K — a 75.5% year-over-year decrease (period ending June 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Biocept reported $550K in inventory as of June 2023. That compares with $2.2M in the prior-year period — down 75.5% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current inventory of $550K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Biocept, and consider following BIOC for alerts when major investors trade the stock.

Biocept is classified in the Healthcare sector. On inventory, it currently shows $550K. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing BIOC with unrelated industries.